- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01965444
A Test of the Investigational SEM Scanner
December 23, 2013 updated by: Bruin Biometrics, LLC
An Investigational, Non-significant Risk Study to Collect Data Needed to Analyze Readings Given by the SEM Scanner Point of Care 200 Series (SEM POC 200) and Its Ability to Detect Sub Epidermal Moisture.
The objective of this study is to establish required data for SEM Scanner analysis of the readings given by the SEM Scanner in the target patient population..
In order to better understand the data this non-invasive scanner provides a collection of data/readings is required to be collected in a certain population.
This will help with clinical interpretation of the numbers and readings this device will provide.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Worcester, Massachusetts, United States, 01655
- UMASS Memorial Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Intensive Care Units
Description
Inclusion Criteria:
- Subjects are 18 years of age or older.
- Subject or health care proxy is willing and able to provide informed consent for enrollment.
- Subject is agreeable to having skin assessments, blanchability tests, and SEM Scanner readings performed daily at all anatomical sites for a duration of five (5) days, with photography as needed.
- Subject is admitted to an intensive Care Unit (ICU) and has an anticipated ICU course of 48 hours or greater.
- Subject is not Comfort Measures Only (CMO).
- Subject is anticipated to be bedridden for ore than 6 hours per day.
- All four (4) of the subject's anatomical sites in question (sternum, sacrum, left heel and right heel) are accessible for scanning (e.g., no cast or medical device present such that heels are not accessible).
Exclusion Criteria:
- Subject has broken skin or scar tissue at the sternum, sacrum, left heel or right heel.
- Subjects for whom the physical act of performing the inspections and measurements required in this study are contra-indicated, as determined by the principal investigator or attending physician.
- Subjects or legal representatives who are unable to understand the aims and objectives of the trial.
- Presence of any condition(s) which seriously compromise(s) the subject's ability to complete this study, or has a known history of poor adherence with medical treatment.
- Subject is pregnant.
- Subject is incarcerated.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Descriptive statistic measurements
Time Frame: 5 day study period
|
The endpoint for this study is the establishment of descriptive statistics around readings given by the SEM Scanner.
|
5 day study period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Timothy Emhoff, MD, UMASS Memorial Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2013
Primary Completion (Actual)
October 1, 2013
Study Completion (Actual)
October 1, 2013
Study Registration Dates
First Submitted
October 16, 2013
First Submitted That Met QC Criteria
October 16, 2013
First Posted (Estimate)
October 18, 2013
Study Record Updates
Last Update Posted (Estimate)
December 24, 2013
Last Update Submitted That Met QC Criteria
December 23, 2013
Last Verified
October 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SEM200-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pressure Ulcers
-
KLOX Technologies Inc.CompletedPressure Ulcers Stage II | Pressure Ulcers Stage IIICanada
-
EmoledRecruitingPressure Ulcer | Pressure Ulcers Stage II | Pressure Ulcers Stage III | Pressure SoreItaly
-
ULURU Inc.United States Department of DefenseRecruitingPressure Ulcers Stage II | Pressure Ulcers Stage III | Pressure Ulcer, Stage IVUnited States
-
Signorini Medicale S.r.l.Opera CRO, a TIGERMED Group CompanyNot yet recruitingBurn Wound | Pressure Ulcers Stage II | Pressure Ulcers Stage IIIRomania
-
Charite University, Berlin, GermanyCompleted
-
Central Arkansas Veterans Healthcare SystemAbbottTerminatedPressure UlcersUnited States
-
Leaf Healthcare, Inc.Centauri Medical, Inc.Completed
-
Hill-RomCompletedPressure UlcersUnited States
-
Molnlycke Health Care ABCompleted